Related Experiment Video

Updated: Aug 29, 2026

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP
07:55

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Published on: October 17, 2015

X11alpha impairs gamma- but not beta-cleavage of amyloid precursor protein

Gwendalyn D King1, Kay Cherian, R Scott Turner

  • 1Neuroscience Program, University of Michigan, Ann Arbor, Michigan 48105, USA.

Journal of Neurochemistry
|February 6, 2004
PubMed

Insights

The neuronal protein X11alpha inhibits beta-amyloid (Abeta) secretion by affecting amyloid precursor protein (APP) trafficking to gamma-secretase, not by directly inhibiting enzyme activity.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • The X11alpha protein binds amyloid precursor protein (APP) and influences its processing.
  • The exact mechanism by which X11alpha inhibits beta-amyloid (Abeta) secretion remains unclear.
  • Previous studies suggest X11alpha affects gamma-secretase but not beta-secretase activity.

Purpose of the Study:

  • To elucidate the mechanism by which X11alpha inhibits Abeta secretion.
  • To determine whether X11alpha directly inhibits beta-secretase (BACE-1) or gamma-secretase activity.
  • To investigate the role of X11alpha in APP trafficking and its interaction with secretase complexes.

Main Methods:

  • Coexpression of X11alpha, APP variants, BACE-1, and presenilin-1 (PS-1) in HEK293 cells.
  • Analysis of Abeta40 and Abeta42 secretion levels.
  • Assessment of APP processing to C99 by BACE-1.
  • Cell-free assays to evaluate X11alpha's effect on APP C-terminal fragment catabolism.
  • Investigation of X11alpha's interaction with PS-1.

Main Results:

  • X11alpha inhibited Abeta40 and Abeta42 secretion from APPswe and C99, suggesting gamma-secretase involvement.
  • X11alpha did not inhibit BACE-1 activity on APP or APPswe.
  • X11alpha did not inhibit gamma-secretase cleavage of Notch.
  • X11alpha did not directly inhibit APP C-terminal fragment catabolism in cell-free assays.
  • X11alpha's interaction with PS-1 did not affect gamma-secretase activity.

Conclusions:

  • X11alpha inhibits Abeta secretion by potentially impairing APP trafficking to gamma-secretase complexes.
  • X11alpha acts as a specific inhibitor by targeting the substrate (APP) rather than the enzyme.
  • This mechanism suggests X11alpha functions as a specific gamma-secretase inhibitor through substrate-directed effects.

More Related Videos

Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase11:57

Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase

Published on: June 24, 2025

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Protein Folding Quality Check in the RER01:29

Protein Folding Quality Check in the RER

ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...